1Keall PJ, Lammering G, Lin PS, et al. Tumor control probability predictions for genetic radiotherapy. Int J Radiat Oncol Biol Phys,2003,57:255-263.
2Zeng M, Cerniglia GJ, Eck SL, et al. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gene Ther, 1997, 8:1025-1032.
3Jain PT, Gewirtz DA. Sustained enhancement of liposome-mediated gene delivery and gene expression in human breast tumor cells by ionizing radiation. Int J Radiat Biol, 1999,75:217-223.
4Gupta VK, Park JO,Jaskowiak NT, et al. Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol, 2002,9:500-504.
5HannaN, Nemunaitis J, Cunningham CC,et al. AphaseⅠstudy of human necrosis factor-alpha gene transfer with radiation therapy for advanced solid tumors. Proc Am Soc Clin Oncol,2002,21:344.
6Bray D, Yu SZ, Koprowski H, et al. Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer. Arch Otolaryngol Head Neck Surg,2003,129:618-622.
7Hillman GG, Xu M, Wang Y, et al. Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma. Hum Gene Ther, 2003,14:763-775.
8Kambara H, Tamiya T, Ono Y,et al. Combined radiation end gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes. Cancer Gene Ther,2002,9:840-845.
9Miyagi T, Koshida K, Hori O,et al. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system. J Gene Med, 2003,5:30-37.
10Freytag SO,Paielli D,Wing M,et al. Efficacy and toxicity of replicationcompetent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model.Int J Radiat Oncol Biol Phys,2002,54:873-885.
二级参考文献13
1Yumi Knegae, Miho Makimura and Izumu Satio. A simple and efficient method for purifica-tion of infections recombinant adenovirus. Jpn J Med Sci Biol, 1994,47:157-166.
2Brand K, Klocke R, Pobetaling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999, 6: 1054-1063.
3Li JH, Lax SA,Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys,1999, 3:607-616.
4Clayman GL,el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol, 1998, 6: 2221-2232.
5Gary L, Clayman, Douglas K, et al. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head nad neck cancer. Clin Cancer Res, 1999, 5: 1715-1722.
6Lianglin Zhang, Dihua Yu, Mei Hu, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res, 2000,60:3655-3661.
7Zhang EP, Lian PG, Cai KL,et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1 302 patients. Int J Radiat Oncol Biol Phys, 1989,16: 301-305.
8Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5307 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys, 1992,20:261-270.
9Erkal HS, Serin M, Cakmark A, et al. Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radither Oncl, 2001; 3:247-256.
10Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the nasopharynx- an analysis of treatment results in 149 consecutive patients. Acta Oncol, 2001, 7: 801-809.
